Earnings Feed
Start Free
Home/Filings/4/0001179110-14-014708
4//SEC Filing

HEALTH NET INC 4

Accession 0001179110-14-014708

CIK 0000916085operating
View on SEC.govCompany Profile

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 4:43 PM ET

Size

29.5 KB

Accession

0001179110-14-014708

Insider Transaction Report

Form 4
Period: 2014-09-29
HEALTH NET INCHNT
ESCARRA VICKI B
Director
Transactions
  • Sale

    Common Stock

    2014-09-29$46.65/sh−3,931$183,381→ 17,852 total
  • Sale

    Common Stock

    2014-09-29$46.46/sh−9,500$441,370→ 19,952 total
  • Sale

    Common Stock

    2014-09-29$46.70/sh−1,100$51,370→ 17,852 total
  • Exercise/Conversion

    Common Stock

    2014-09-29$15.30/sh+7,366$112,700→ 25,218 total
  • Sale

    Common Stock

    2014-09-29$46.69/sh−2,100$98,049→ 17,852 total
  • Exercise/Conversion

    Common Stock

    2014-09-29$28.08/sh+11,600$325,728→ 29,452 total
  • Sale

    Common Stock

    2014-09-29$46.47/sh−6,266$291,181→ 18,952 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2014-09-29−7,366→ 0 total
    Exercise: $15.30Exp: 2016-05-22→ Common Stock (7,366 underlying)
  • Exercise/Conversion

    Common Stock

    2014-09-29$23.51/sh+12,859$302,315→ 30,711 total
  • Sale

    Common Stock

    2014-09-29$46.43/sh−8,928$414,527→ 21,783 total
  • Sale

    Common Stock

    2014-09-29$45.69/sh−4,468$204,143→ 17,852 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2014-09-29−12,859→ 0 total
    Exercise: $23.51Exp: 2017-05-13→ Common Stock (12,859 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2014-09-29−11,600→ 0 total
    Exercise: $28.08Exp: 2018-05-09→ Common Stock (11,600 underlying)
Footnotes (13)
  • [F1]The sale of Common Stock by the Reporting Person, as reported on this Form 4, was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 (the "Act"), as amended.
  • [F10]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.58 to $46.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  • [F11]The 2008 Grant became exercisable in 33 1/3% increments on each of the first, second, and third anniversaries of May 9, 2008, the grant date.
  • [F12]The 2009 Grant became exercisable in 33 1/3% increments on each of the first, second, and third anniversaries of May 22, 2009, the grant date.
  • [F13]The 2010 Grant became exercisable in 33 1/3% increments on each of the first, second, and third anniversaries of May 13, 2010, the grant date.
  • [F2]Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 9, 2008 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2008 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2008 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.64 to $46.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  • [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.64 to $46.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  • [F5]Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 22, 2009 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2009 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2009 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  • [F6]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.66 to $46.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  • [F7]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.67 to $46.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  • [F8]Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 13, 2010 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2010 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2010 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  • [F9]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.58 to $46.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.

Documents

1 file

Issuer

HEALTH NET INC

CIK 0000916085

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000916085

Filing Metadata

Form type
4
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:43 PM ET
Size
29.5 KB
View on SEC.gov